Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
Public ClinicalTrials.gov record NCT02078570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for the presence of a malignancy in the breast as compared to your breast evaluation assessment conducted by your physician.
Study identification
- NCT ID
- NCT02078570
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 25 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2014 (Type not available)
- Primary completion
- Jul 2017 (Estimated)
- Completion
- Not listed
- Last update posted
- Sep 30, 2016
Started 2014
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital & Medical Center | Phoenix | Arizona | 85013 | — |
| Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| Sutter Institute | Sacramento | California | 95816 | — |
| Scripps | San Diego | California | 92103 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Sinai Grace | Detroit | Michigan | 48235 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55095 | — |
| Summit Medical Group Breast Center New Jersey | Berkeley Heights | New Jersey | 07922 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Mercy Womens Center | Oklahoma City | Oklahoma | 73120 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Avera Research Institute | Sioux Falls | South Dakota | 57105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02078570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02078570 live on ClinicalTrials.gov.